|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Surveillance Epidemiology and End Results
(SEER) Fact Sheets: Pancreas. Web site. http://seer.cancer.gov/. Accessed July 15, 2016.
|
|
3
|
Aarnink A, Richard C, Truntzer C, Vincent
J, Bengrine L, Vienot A, Borg C and Ghiringhelli F: Baseline
splenic volume as a surrogate marker of FOLFIRINOX efficacy in
advanced pancreatic carcinoma. Oncotarget. 9:25617–25629.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Paulson AS, Tran Cao HS, Tempero MA and
Lowy AM: Therapeutic advances in pancreatic cancer.
Gastroenterology. 144:1316–1326. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
De Luca R, Blasi L, Alù M, Gristina V and
Cicero G: Clinical efficacy of nab-paclitaxel in patients with
metastatic pancreatic cancer. Drug Des Devel Ther. 12:1769–1775.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tang Y, Cao G, Zhao G, Wang C and Qin Q:
LncRNA differentiation antagonizing non-protein coding RNA promotes
proliferation and invasion through regulating miR-135a/NLRP37 axis
in pancreatic cancer. Invest New Drugs. 38:714–721. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Peng W and Jiang A: Long noncoding RNA
CCDC26 as a potential predictor biomarker contributes to
tumorigenesis in pancreatic cancer. Biomed Pharmacother.
83:712–717. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang X, Feng W, Zhang J, Ge L, Zhang Y,
Jiang X, Peng W, Wang D, Gong A and Xu M: Long non-coding RNA PVT1
promotes epithelial-mesenchymal transition via the TGF-β/Smad
pathway in pancreatic cancer cells. Oncol Rep. 40:1093–1102.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang M, Zhao Y, Zhang Y, Wang D, Gu S,
Feng W, Peng W, Gong A and Xu M: LncRNA UCA1 promotes migration and
invasion in pancreatic cancer cells via the hippo pathway. Biochim
Biophys Acta Mol Basis Dis. 1864:1770–1782. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gao H, Gong N, Ma Z, Miao X, Chen J, Cao Y
and Zhang G: LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth
and invasion through regulating the miR-204/HMGB1 axis. Int J Biol
Macromol. 116:545–551. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
She K, Huang J, Zhou H, Huang T, Chen G
and He J: lncRNA-SNHG7 promotes the proliferation, migration and
invasion and inhibits apoptosis of lung cancer cells by enhancing
the FAIM2 expression. Oncol Rep. 36:2673–2680. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang MW, Liu J, Liu Q, Xu QH, Li TF, Jin S
and Xia TS: LncRNA SNHG7 promotes the proliferation and inhibits
apoptosis of gastric cancer cells by repressing the P15 and P16
expression. Eur Rev Med Pharmacol Sci. 21:4613–4622.
2017.PubMed/NCBI
|
|
14
|
Ren J, Yang Y, Xue J, Xi Z, Hu L, Pan SJ
and Sun Q: Long noncoding RNA SNHG7 promotes the progression and
growth of glioblastoma via inhibition of miR-5095. Biochem Biophys
Res Commun. 496:712–718. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cheng D, Fan J, Ma Y, Zhou Y, Qin K, Shi M
and Yang J: LncRNA SNHG7 promotes pancreatic cancer proliferation
through ID4 by sponging miR-342-3p. Cell Biosci.
9(28)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Zhang Z, Che X, Yang N, Bai Z, Wu Y, Zhao
L and Pei H: MiR-135b-5p Promotes migration, invasion and EMT of
pancreatic cancer cells by targeting NR3C2. Biomed Pharmacother.
96:1341–1348. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cai H, Yao J, An Y, Chen X, Chen W, Wu D,
Luo B, Yang Y, Jiang Y, Sun D and He X: LncRNA HOTAIR acts a
competing endogenous RNA to control the expression of notch3 via
sponging miR-613 in pancreatic cancer. Oncotarget. 8:32905–32917.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang J, Guo XJ, Ding YM and Jiang JX:
MiR-1181 inhibits invasion and proliferation via STAT3 in
pancreatic cancer. World J Gastroenterol. 23:1594–1601.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lin F, Wang X, Jie Z, Hong X, Li X, Wang M
and Yu Y: Inhibitory effects of miR-146b-5p on cell migration and
invasion of pancreatic cancer by targeting MMP16. J Huazhong Univ
Sci Technolog Med Sci. 31(509)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
He H, Hao SJ, Yao L, Yang F, Di Y, Li J,
Jiang YJ, Jin C and Fu DL: MicroRNA-218 inhibits cell invasion and
migration of pancreatic cancer via regulating ROBO1. Cancer Biol
Ther. 15:1333–1339. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cuccurullo V and Mansi L: AJCC cancer
staging handbook: From the AJCC cancer staging manual (7th
edition). Eur J Nucl Med Mol Imaging. 38(408)2011.
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Harden VA and Hannaway C: National
Institutes of Health (NIH). In: Encyclopedia of Life Sciences. New
York, John Wiley & Sons, Ltd, 2001.
|
|
25
|
Schober P, Boer C and Schwarte LA:
Correlation coefficients: Appropriate use and interpretation.
Anesth Analg. 126:1763–1768. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xu W, Chang J, Du X and Hou J: Long
non-coding RNA PCAT-1 contributes to tumorigenesis by regulating
FSCN1 via miR-145-5p in prostate cancer. Biomed Pharmacother.
95:1112–1118. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Huo X and Wang H, Huo B, Wang L, Yang K,
Wang J, Wang L and Wang H: FTX contributes to cell proliferation
and migration in lung adenocarcinoma via targeting miR-335-5p/NUCB2
axis. Cancer Cell Int. 20(89)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sun J, Zhang P, Yin T, Zhang F and Wang W:
Upregulation of LncRNA PVT1 facilitates pancreatic ductal
adenocarcinoma cell progression and glycolysis by regulating
MiR-519d-3p and HIF-1A. J Cancer. 11:2572–2579. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Guo X, Zhang Y, Liu L, Yang W and Zhang Q:
HNF1A-AS1 regulates cell migration, invasion and glycolysis via
modulating miR-124/MYO6 in colorectal cancer cells. Onco Targets
Ther. 13:1507–1518. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li H, Yao G, Zhai J, Hu D and Fan Y:
LncRNA FTX promotes proliferation and invasion of gastric cancer
via miR-144/ZFXAxis. Onco Targets Ther. 12:11701–11713.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Feng Y, Gao L, Cui G and Cao Y: LncRNA
NEAT1 facilitates pancreatic cancer growth and metastasis through
stabilizing ELF3 mRNA. Am J Cancer Res. 10:237–248. 2020.PubMed/NCBI
|
|
33
|
Zhang C, Zhu B, Li XB, Cao YQ, Yang JC, Li
X, Liu YX and Wang YB: Long non-coding RNA SNHG7 promotes migration
and invasion of melanoma via upregulating SOX4. Eur Rev Med
Pharmacol Sci. 23:4828–4834. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang YH, Huo BL, Li C, Ma G and Cao W:
Knockdown of long noncoding RNA SNHG7 inhibits the proliferation
and promotes apoptosis of thyroid cancer cells by downregulating
BDNF. Eur Rev Med Pharmacol Sci. 23:4815–4821. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xu C, Zhou J, Wang Y, Wang A, Su L, Liu S
and Kang X: Inhibition of malignant human bladder cancer phenotypes
through the down-regulation of the long non-coding RNA SNHG7. J
Cancer. 10:539–546. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Luo X, Song Y, Tang L, Sun DH and Ji DG:
LncRNA SNHG7 promotes development of breast cancer by regulating
microRNA-186. Eur Rev Med Pharmacol Sci. 22:7788–7797.
2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sun X, Huang T, Liu Z, Sun M and Luo S:
LncRNA SNHG7 contributes to tumorigenesis and progression in breast
cancer by interacting with miR-34a through EMT initiation and the
notch-1 pathway. Eur J Pharmacol. 856(172407)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chen W, Ye L, Wen D and Chen F: MiR-490-5p
inhibits hepatocellular carcinoma cell proliferation, migration and
invasion by directly regulating ROBO1. Pathol Oncol Res. 25:1–9.
2019.PubMed/NCBI View Article : Google Scholar
|
